AUR107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AUR107, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) [Phase 1]